About
Technology
Issues
FAQ
Links
Official Page
Cardiovascular risk reduction in hypertension: angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.